Amin · Proceedings (Baylor University. Medical Center) 2026 · systematic review and meta-analysis · n=7 studies (9702 patients)

Efficacy and safety of exercise for hypertrophic cardiomyopathy: a systematic review and meta-analysis.

Cited 0 times in the scientific literature.

Level 2 - randomized trial

Systematic review and meta-analysis combining randomized controlled trials (n=3) and observational studies (n=4).

PubMed 42269051 · doi:10.1080/08998280.2026.2667666 · record verified 2026-08-29

What was done

A systematic review and meta-analysis searched PubMed, Web of Science, Scopus, Embase, and CENTRAL up to April 2025 for studies assessing exercise in hypertrophic cardiomyopathy (HCM). Seven studies (3 randomized controlled trials and 4 observational studies) with 9,702 total patients were included. Continuous outcomes were pooled as mean differences (MDs) or standardized mean differences (SMDs) and dichotomous outcomes as risk ratios (RRs), all with 95% confidence intervals (CIs).

What was found

Compared to controls, exercise was significantly associated with increased peak VO2 (MD: 1.78 mL/kg/min; 95% CI [0.98, 2.59]; P < 0.01), increased VO2 at anaerobic threshold (MD: 1.27 mL/kg/min; 95% CI [0.34, 2.20]; P < 0.01), reduced body mass index (MD: -0.67 kg/m2; 95% CI [-1.17, -0.18]; P < 0.01), reduced echocardiographic left ventricular wall thickness (MD: -0.56 mm; 95% CI [-1.01, -0.11]; P = 0.01), improved quality of life physical factor (SMD: 0.66; 95% CI [0.34, 0.97]; P < 0.01), and lower all-cause mortality (RR: 0.71; 95% CI [0.60, 0.85]; P < 0.01). Arrhythmia risk was not increased.

Why it matters

These findings suggest that structured exercise is safe and physiologically beneficial in patients with hypertrophic cardiomyopathy, challenging traditional blanket restrictions on physical activity.

Limits

Only 3 of the 7 studies were randomized controlled trials, and the mortality reduction was primarily driven by observational studies susceptible to residual confounding. Specific exercise prescriptions, adherence rates, and long-term safety endpoints were not detailed in the abstract.

Cited by